BeOne Medicines AG
NASDAQONC short interest surges 37% over one week to 1.17% of free float, driven by recent stock weakness and analyst optimism disconnect.
ONC reports today with the analyst community broadly constructive, the stock up 15% over the past month, and positioning that reads more relaxed than charged. The options market shows no sign of pre-earnings anxiety.…
BeOne Medicines enters July with short sellers voting heavily with their feet — and the borrow market confirming there's almost no conviction left on the bearish side. Short interest has collapsed over the past month,…
Snapshot as of 20 Sept 2026
ONC reports its first-quarter 2026 results today — and the most telling signal heading in is not short positioning but the rapid accumulation of bullish analyst coverage on a stock that remains well below most price…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ONC — free to start on ORTEX.
Sign up for free →Open ONC on ORTEX